- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
New CT rule-out examination cuts patient x-ray exposure
High radiation exposure has been the bogeyman keeping the cardiac CT triple rule-out exam for chest pain from widespread application.
High radiation exposure has been the bogeyman keeping the cardiac CT triple rule-out exam for chest pain from widespread application. The use of radiation dose reduction techniques addresses that concern.
Dr. Kevin Takakuwa and colleagues at Thomas Jefferson University reviewed data from 267 consecutive patients who underwent triple rule-out cardiac CT angiography after presenting to the emergency roon with symptoms of acute coronary syndrome. Ninety-five patients underwent the triple rule-out CTA protocol with tube current modulation, and 172 did so without it. Investigators found that patients undergoing triple rule-out without tube current modulation received average effective radiation doses of 18 mSv. Those getting the exam with tube current modulation, however, had effective radiation doses reduced by more than 50% without image quality loss. Findings were published in the American Journal of Roentgenology (2009;192[4]:866-872).
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
